Accelerating Development of SARS-CoV-2 Vaccines - The Role for Controlled Human Infection Models.

Meagan E Deming Nelson L Michael Merlin Robb Myron S Cohen Kathleen M Neuzil

N Engl J Med

From the Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore (M.E.D., K.M.N.), the Center for Infectious Diseases Research, Walter Reed Army Institute of Research, Silver Spring (N.L.M.), and the Henry Jackson Foundation, Bethesda (M.R.) - all in Maryland; and the Institute for Global Health and Infectious Diseases, School of Medicine, University of North Carolina, Chapel Hill (M.S.C.).

Published: September 2020

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7968616	PMC
http://dx.doi.org/10.1056/NEJMp2020076	DOI Listing

Publication Analysis

Top Keywords

accelerating development

development sars-cov-2

sars-cov-2 vaccines

vaccines role

role controlled

controlled human

human infection

infection models

accelerating

sars-cov-2

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!